Loading...

Illumina, Inc.

ILMN•NASDAQ
Healthcare
Medical - Diagnostics & Research
$99.66
$-2.14(-2.10%)

Illumina, Inc. (ILMN) Stock Overview

Explore Illumina, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.2/100

Key Financials

Market Cap15.3B
P/E Ratio12.54
EPS (TTM)$7.90
ROE0.53%
Fundamental Analysis

AI Price Forecasts

1 Week$83.53
1 Month$82.48
3 Months$108.12
1 Year Target$81.53

ILMN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Illumina, Inc. (ILMN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $81.53.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.54 and a market capitalization of 15.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.61%
5-Day Change
-5.49%
1-Month Change
-17.11%
3-Month Change
-47.87%
6-Month Change
-50.43%
Year-to-Date (YTD) Change
-45.57%
1-Year Change
-44.10%
3-Year Change
-79.13%
5-Year Change
-74.67%
All-Time (Max) Change
274.46%

Contact Information

https://www.illumina.com
858 202 4500
5200 Illumina Way, San Diego, CA, 92122

Company Facts

8,970 Employees
IPO DateJul 28, 2000
CountryUS
Actively Trading

Frequently Asked Questions

;